Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
Thao D. V. Le, Payam A. Fathi, Amanda B. Watters, et al.
Molecular Metabolism (2023) Vol. 72, pp. 101718-101718
Open Access | Times Cited: 22

Showing 22 citing articles:

FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Timothy P. Rolph, Madeline Knott, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 562-576
Closed Access | Times Cited: 30
Current status and future perspectives of FGF21 analogues in clinical trials
Zara Siu Wa Chui, Qing Shen, Aimin Xu
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 371-384
Closed Access | Times Cited: 18
Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota
Tingting Zhang, Wei Wang, Jiayu Li, et al.
Nature Microbiology (2025)
Closed Access | Times Cited: 2
Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice
Jia Nuo Feng, Weijuan Shao, Lin Yang, et al.
Nutrition and Diabetes (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Protein appetite as an integrator in the obesity system: the protein leverage hypothesis
David Raubenheimer, Stephen J. Simpson
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1888
Open Access | Times Cited: 20
Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence
Emma Rose McGlone, Steve Bloom, Tricia Tan
Journal of Endocrinology (2024) Vol. 261, Iss. 3
Open Access | Times Cited: 7
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Zara Siu Wa Chui, Yaqian Xue, Aimin Xu
Medical Review (2024) Vol. 4, Iss. 2, pp. 158-168
Open Access | Times Cited: 5
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Jia Nuo Feng, Tianru Jin
Medical Review (2024) Vol. 4, Iss. 4, pp. 312-325
Open Access | Times Cited: 5
The Chimeric Peptide (GEP44) Reduces Body Weight, Energy Intake, and Energy Expenditure in Diet-Induced Obese Rats
Matvey Goldberg, James E. Blevins, Tami Wolden‐Hanson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Protein phosphatase 6 as an important downstream target of fibroblast growth 21 and its therapeutic analogues in attenuating MASH development
Jia Nuo Feng, Qingchun Tong, Tianru Jin
Obesity Medicine (2025), pp. 100602-100602
Closed Access
The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats
Matvey Goldberg, James E. Blevins, Tami Wolden‐Hanson, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3032-3032
Open Access
Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids
Matteo Fiorenza, Antonio Checa, Rasmus M. Sandsdal, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101629-101629
Open Access | Times Cited: 3
Obesity, Osteoarthritis, and Myokines: Balancing Weight Management Strategies, Myokine Regulation, and Muscle Health
Daniel Timofte, Răzvan Tudor, Veronica Mocanu, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4231-4231
Open Access | Times Cited: 2
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 5
Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
Jenpei Lee, Yingxiao Li, Juei‐Tang Cheng, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 538-538
Open Access | Times Cited: 1
FGF21 mediating sex dependent response to dietary macronutrients
Karla A. Soto Sauza, Karen K. Ryan
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. e1689-e1696
Closed Access | Times Cited: 1
Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice
Tianru Jin, Jia Nuo Feng, Weijuan Shao, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Harnessing the Promise of the Cold Stress Response for Acute Brain Injury and Critical Illness in Infants and Children
Travis C. Jackson, Jeremy R. Herrmann, Ericka L. Fink, et al.
Pediatric Critical Care Medicine (2023) Vol. 25, Iss. 3, pp. 259-270
Closed Access | Times Cited: 3
Hormone based therapy and crosstalk beyond hormones
Tianru Jin
Medical Review (2024) Vol. 4, Iss. 4, pp. 257-261
Open Access
A combination of <em>Citrus aurantifolia</em> fruit rind and <em>Theobroma cacao</em> seed extracts supplementation enhances metabolic rates in overweight subjects: a randomized, placebo-controlled, cross-over study
Nihal Kumar Reddy Ammatalli, Sesha Sai Siva Krishna Kuricheti, Sudipta Veeramachaneni, et al.
Food & Nutrition Research (2024) Vol. 68
Open Access
The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
Maria Moreno‐Lopez, Isaline Louvet, Nathalie Delalleau, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 885-898
Closed Access
FGF21 Analogue PF-05231023 on Alcohol Consumption and Neuronal Activity in the Nucleus Accumbens
Bart J. Cooley, Cassandra V. Occelli Hanbury-Brown, Eun A Choi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1

Scroll to top